Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lena-Sophie Menig-Benzig
Observed names:
L.-S. Menig-Benzig,
Lena‐Sophie Menig,
Lena‐Sophie Menig‐Benzig
Institutions:
Universitätsklinikum Tübingen,
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology,
University of Tübingen
Observed institutions:
Universitätsklinikum Tübingen,
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology,
University of Tübingen
ORCID:
0000-0001-9086-8118
Observed ORCID:
0000-0001-9086-8118
OpenAlex ID:
A5094120025
Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
2022
·
Anna Reustle
, Lena‐Sophie Menig
, et al.
·
Clinical and Translational Medicine
·
45
PDF
Drug targeting of the monocarboxylate transporter MCT4 is a novel treatment strategy for metastatic ccRCC
2025
·
Lena-Sophie Menig-Benzig
, Viktoria Stühler
, et al.
·
Pharmacological Research
·
6
Targeting ACKR3/CXCR7 enhances platelet anticoagulant acylcarnitines and modulates procoagulant function
2026
·
Xiaoqing Fu
, Adrian Brun
, et al.
·
Blood
·
2
OC 07.1 Platelet ACKR3/CXCR7 Induced AMPKThr172-ACCSer79 pathway Regulates Procoagulant Functions: Implications for Immunothrombosis
2026
·
Adrian Brun
, Xiaoqing Fu
, et al.
·
Research and Practice in Thrombosis and Haemostasis
PDF
Prenatal Phenotypic Features of Five Fetal Cases With RNU4ATAC ‐Associated Microcephalic Osteodysplastic Primordial Dwarfism Type I
2026
·
Alexandra Liebmann
, Tanja Richter
, et al.
·
Prenatal Diagnosis
Therapeutic influence of ACKR3/CXCR7 in inducing Anticoagulant Acylcarnitines: implications for Deep Vein Thrombosis and Coronary Artery Disease
2024
·
J. A. Bucio García
, X. Fu
, et al.
·
Hämostaseologie
Show more works
View as search
Works count:
6
Citation count:
53
H-index:
2
I10-index:
1
Year
Topic
Type